Artwork

Uppsala Monitoring Centre에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Uppsala Monitoring Centre 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

#29 When medicines change our behaviour – Michele Fusaroli

30:30
 
공유
 

Manage episode 424661236 series 2749727
Uppsala Monitoring Centre에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Uppsala Monitoring Centre 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Medicines can affect our personality in positive ways, but they may also lead to destructive behaviours that can damage our relationships, finances, and overall quality of life. Michele Fusaroli from the University of Bologna explains how to diagnose and treat drug-induced impulse control disorders.

Tune in to find out:

  • Which medicines may cause impulsivity
  • What the ‘four knights’ of impulsivity are
  • How patient stories can help detect these conditions

Want to know more?

This review by Daniel Weintraub summarises twenty years of research on impulse control disorders in Parkinson’s disease.
In 2003, Driver-Dunckley and colleagues in the US published the first case series linking pathological gambling to dopamine agonists.
In 2016, the US Food and Drug Administration warned about impulse-control problems associated with the antipsychotic drug aripiprazole.
Michele and colleagues in Italy have investigated the mechanisms and burden of drug-induced impulsivity.
In their 2024 guidelines for managing impulsivity in Parkinson's disease, an expert consensus group highlighted the pivotal role of caregivers and of psychosocial interventions.
Finally, these are the Drug Safety Matters episodes cited in the interview:

Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.

  continue reading

챕터

1. #29 When medicines change our behaviour – Michele Fusaroli (00:00:00)

2. Intro (00:00:15)

3. Welcome, Michele! (00:01:53)

4. Body versus mind (00:02:47)

5. Tamoxifen and brain fog (00:05:38)

6. Drug-induced impulse control disorders (00:06:36)

7. Drugs and mechanisms (00:08:46)

8. Frequency of impulse control disorders (00:09:58)

9. Risk factors (00:11:07)

10. Impact on quality of life (00:11:45)

11. First identification (00:14:16)

12. Third-generation antipsychotics (00:16:02)

13. Diagnosis (00:19:00)

14. Coping strategies (00:20:45)

15. Assessing impulsivity reports (00:23:52)

16. Final advice (00:26:40)

17. Outro (00:29:01)

51 에피소드

Artwork
icon공유
 
Manage episode 424661236 series 2749727
Uppsala Monitoring Centre에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Uppsala Monitoring Centre 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Medicines can affect our personality in positive ways, but they may also lead to destructive behaviours that can damage our relationships, finances, and overall quality of life. Michele Fusaroli from the University of Bologna explains how to diagnose and treat drug-induced impulse control disorders.

Tune in to find out:

  • Which medicines may cause impulsivity
  • What the ‘four knights’ of impulsivity are
  • How patient stories can help detect these conditions

Want to know more?

This review by Daniel Weintraub summarises twenty years of research on impulse control disorders in Parkinson’s disease.
In 2003, Driver-Dunckley and colleagues in the US published the first case series linking pathological gambling to dopamine agonists.
In 2016, the US Food and Drug Administration warned about impulse-control problems associated with the antipsychotic drug aripiprazole.
Michele and colleagues in Italy have investigated the mechanisms and burden of drug-induced impulsivity.
In their 2024 guidelines for managing impulsivity in Parkinson's disease, an expert consensus group highlighted the pivotal role of caregivers and of psychosocial interventions.
Finally, these are the Drug Safety Matters episodes cited in the interview:

Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.

  continue reading

챕터

1. #29 When medicines change our behaviour – Michele Fusaroli (00:00:00)

2. Intro (00:00:15)

3. Welcome, Michele! (00:01:53)

4. Body versus mind (00:02:47)

5. Tamoxifen and brain fog (00:05:38)

6. Drug-induced impulse control disorders (00:06:36)

7. Drugs and mechanisms (00:08:46)

8. Frequency of impulse control disorders (00:09:58)

9. Risk factors (00:11:07)

10. Impact on quality of life (00:11:45)

11. First identification (00:14:16)

12. Third-generation antipsychotics (00:16:02)

13. Diagnosis (00:19:00)

14. Coping strategies (00:20:45)

15. Assessing impulsivity reports (00:23:52)

16. Final advice (00:26:40)

17. Outro (00:29:01)

51 에피소드

Semua episod

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드